A Collaborative Validation Study for the Gpt Delta Mouse Using N-propyl-N-nitrosourea, Diethylnitrosamine, Mitomycin C and Chlorambucil: A Summary Report of the Third Collaborative Study of the Transgenic Mouse Mutation Assay by JEMS/MMS

  • Yajima, Nobuhiro (Research Institute of Life Science, Snow Brand Milk Products Co., Ltd.) ;
  • Hyogo, Atsushi (Medicinal Safety Research Laboratories, Sankyo Co., Ltd.) ;
  • Tamura, Hironobu (Nippon Shinyaku Co., Ltd., Safety Laboratory) ;
  • Nakajima, Madoka (Biosafety Research (An-pyo) Center, Foods, Drugs & Pesticides) ;
  • Nohmi, Takehiko (Division of Genetics and Mutagenesis, National Institute of Health Sciences)
  • Published : 2003.10.01

Abstract

To validate a novel mouse model, gpt delta, for in vivo mutagenesis, the Mammalian Mutagenesis Society (MMS), a subgroup of the Environmental Mutagen Society of Japan (JEMS) (JEMS/MMS), performed a collaborative study as the third trial for transgenic animal assay. In this mouse model, point mutations and deletions re separately identified by gpt (6-thioguanine-resistant) and Spi- (sensitive to P2 interference) selections, respectively.(omitted)

Keywords